The Department of Health in internal emails rated a failed contractor as “solid” even after its Covid test kits failed clinical trials. Spartan Bioscience Inc. received a $16.6 million cash advance for rush orders of test kits never delivered before it filed for bankruptcy court protection April 6: “We are in good shape.”
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
